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Introduction: Exercise capacity of CF patients is used as a parameter of disease
status and progress. In Israel, there is no data on exercise capacity and daily function
levels of CF patients.
Objectives: The targets of this study were collecting data on CF patients’ aerobic
capacity, validating a physical activity questionnaire in Hebrew and identifying
exercise limits. Results will provide a basis for building individual home exercise
programs to help stabilize patients’ clinical condition.
Methods: Patients (age 12 yrs) underwent cardiopulmonary exercise test, a six
minute walk test and ﬁlled-in physical activity questionnaire. Correlations between
test results were statistically analyzed.
Results: 17 patients [8 males, 9 females, mean age: 20.3 yrs ±6.4 (range: 12−34)]
have completed the study. Pulmonary function test revealed mean FEV1‰ of
87.8‰ ±10.5. Exercise tests showed mean “6 minutes walk” test distance (m)
of 629.9±41.0, mean Vo2 max (ml/min/kg) for males: 46.3±10.0; mean Vo2 Max
(ml/min/kg) and for females: 33.9±5.7. According to the questionnaires mean time
per week of physical activity was 300 min for males and 120 min for females.
Pearson correlation parameter of r = −0.74 was seen between Borg scoring and
VO2max in cardiopulmonary stress test.
Conclusion: Although male patients engaged with higher levels of physical activity
compared to female patients, the VO2 max values of male patients correlated only
with moderate aerobic capacity level. In addition to cardiopulmonary exercise test
we found that a questionnaire is an effective tool to assess daily physical activity in
CF patients. More patients are needed to assess correlations between test results.
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Background: Despite signiﬁcant improvements in the CF treatment, alteration in
body composition is still a common problem which afects the quality of life.
Objectives: This study try to improve the elements of body composition and to
observe the changes after 6 months of supervised physical individualized training
on patients with CF.
Methods: We conducted a 6 months prospective study, on 20 patients (between
14−18 years), in the Romanian National C.F. Centre. The evaluation consisted in:
analysis of corporal composition through bioimpedancy (In-Body 720 device). In
order to rich our purpose regarding the body composition the subjects beneﬁt by
a dietary recomandations and individualized training program 4 times/week with
heart rate between 65−80%.
Results: We noticed important changes in Weight (from 44.84±16.06 to
46.23±16.38, p = 0.0023), proteins (from 7.52±2.422 to 8.425±2.494, p = 0.0002)
and Skeletal muscle mass (20.23±7.226 to 22.03±7.277, p = 0.0002), and also small
changes regarding body water (Intra celular water increased from 17.08±5.554 to
17.82±6.594, and Extra celular water from 10.60±3.274 to 11.47±3.478).
Conclusions: At the end of the study we observed a positive evolution of the body
composition for the majority of pacients included in the study. Impaired breathing
and bacterial infections trigger the body to burn more calories than usual and it
is necessary the increasing of lung function through physiotherapy and dietary
supplement.
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Background: Nebuliser therapy is increasingly utilised in infants with Cystic Fibro-
sis, including colistin or tobramycin for the treatment of Pseudomonas aeruginosa
infection, and DNAse or hypertonic saline (HS) as adjuncts for secretion clearance.
There may however be concern over the tolerability of nebulised therapy, particularly
HS, in patients less than 1 year of age. Prior to commencing nebuliser therapy
we perform a formal treatment challenge under physiotherapist supervision. We
reviewed treatment challenge in infants less than a year of age compared to older
children.
Methods: Prospective evaluation of formal nebuliser challenge in all newly initiated
nebuliser therapy
Results: Over a 15 month period 37 nebuliser challenges were performed in 27
children − 21 to 7% HS, 1 to 3.5% HS (previously unable to tolerate 7% HS), 6
to Tobramycin, 5 to Colistin and 4 to DNAse. There were 5 challenge failures − 2
to tobramycin via eﬂow nebuliser (both subjects subsequently tolerated with medix
nebulisers), and 3 to HS − one subject had >10% decline in FEV1 after 3.5%
HS; one age 2 years vomited after HS challenge, and one age 9 months would not
tolerate the face mask. There was no signiﬁcant difference in tolerability between
infants and older children − in 6 challenges less than 1 year of age (5 for 7% HS
and 1 for Colistin) only one was not tolerated due to the mask (17%), compared
to 4 failures in older children (13%). All patients who tolerated their nebuliser
challenge were successfully commenced on regular therapy.
Conclusions: Nebuliser challenges are feasible and well tolerated even in infants
less than 1 year of age, and are predictive of therapy tolerance.
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The I-neb Adaptive Aerosol Delivery (AAD) System is designed to analyze patient
breathing and emit aerosol only during the inspiratory phase. The I-neb AAD
System can be operated in tidal breathing mode (TBM), in which the user breathes
in a normal manner during treatment, or target inhalation mode (TIM), in which
the user is guided to longer inhalations via feedback from the I-neb device,
depending upon patient preference. Each I-neb device is equipped with a patient
logging system (PLS) that records details about each treatment taken via the device,
including treatment time and mean inhalation time per breath per treatment.
We analyzed PLS data from a 13-week handling study conducted in 49 adult patients
with cystic ﬁbrosis to determine the association of mean inhalation time (time
spent inhaling during each breath) per treatment with the time taken to complete a
treatment (treatment time). Data for 43 patients was analyzed in terms of inhalation
time per breath and treatment time.
Table 1. Cumulative number of patients and mean treatment times for increasing
inhalation time.
Patient TBM TIM
mean inhalation
time category
(s)
Number of
patients (n)
Mean
treatment
time (min)
Number of
patients (n)
Mean
treatment
time (min)
>0.5 20 5.1 23 3.0
>2 12 3.9 22 2.9
>3 10 3.7 20 2.6
>5 5 3.5 17 2.2
8 2 4.1 5 2.4
Most patients using TIM had inhalation times over 5 s, whereas most TBM patients
had inhalation times under 5 s. The mean treatment time for patients using TIM
was between 1 and 2 minutes shorter than for patients using TBM. These results
suggest that patients using TIM would have shorter treatment times.
